The boom in digital tech over COVID means that pharma can move faster than ever – but the industry’s traditional processes for asset approval are still holding timelines back. David Reily examines how ...

Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals ...

Lauren Claxton is a freelance writer with a focus on personal finance and cryptocurrency. She has previously written for Crypto News Australia and was employed as a content writer at Monzi Personal ...